Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2021 Filed Jun 7, 2021 17:05 UTC |
PANEK JAMES PDirector
|
GrantStock Option (right to buy) · Derivative | 18,500 | $0.00 Strike: $18.21 | $0.00 |
DisclosureSEC source: 0001209191-21-038688 · doc4.xml · derivative · entry 1 PANEK JAMES P · CIK 0001217412 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2031-06-02 F1 · derivative.exercise_date: The option vests as to 8.33% of the total shares monthly, commencing July 3, 2021, with 100% of the total shares vested and exercisable on the earlier of the issuer's 2022 annual stockholders meeting or June 3, 2022, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 21:07 UTC |
Sharp ShaliniDirector
|
GrantStock Option (right to buy) · Derivative | 18,500 | $0.00 Strike: $18.21 | $0.00 |
DisclosureSEC source: 0001209191-21-038699 · doc4.xml · derivative · entry 1 Sharp Shalini · CIK 0001377202 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2031-06-02 F1 · derivative.exercise_date: The option vests as to 8.33% of the total shares monthly, commencing July 3, 2021, with 100% of the total shares vested and exercisable on the earlier of the issuer's 2022 annual stockholders meeting or June 3, 2022, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 21:08 UTC |
Wigginton Jon MarcDirector
|
GrantStock Option (right to buy) · Derivative | 18,500 | $0.00 Strike: $18.21 | $0.00 |
DisclosureSEC source: 0001209191-21-038701 · doc4.xml · derivative · entry 1 Wigginton Jon Marc · CIK 0001587487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2031-06-02 F1 · derivative.exercise_date: The option vests as to 8.33% of the total shares monthly, commencing July 3, 2021, with 100% of the total shares vested and exercisable on the earlier of the issuer's 2022 annual stockholders meeting or June 3, 2022, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 21:04 UTC |
Lobacki Joseph MDirector
|
GrantStock Option (right to buy) · Derivative | 18,500 | $0.00 Strike: $18.21 | $0.00 |
DisclosureSEC source: 0001209191-21-038682 · doc4.xml · derivative · entry 1 Lobacki Joseph M · CIK 0001536193 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2031-06-02 F1 · derivative.exercise_date: The option vests as to 8.33% of the total shares monthly, commencing July 3, 2021, with 100% of the total shares vested and exercisable on the earlier of the issuer's 2022 annual stockholders meeting or June 3, 2022, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 21:02 UTC |
Dybbs MichaelDirector
|
GrantStock Option (right to buy) · Derivative | 18,500 | $0.00 Strike: $18.21 | $0.00 |
DisclosureSEC source: 0001209191-21-038677 · doc4.xml · derivative · entry 1 Dybbs Michael · CIK 0001601264 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2031-06-02 F1 · derivative.exercise_date: The option vests as to 8.33% of the total shares monthly, commencing July 3, 2021, with 100% of the total shares vested and exercisable on the earlier of the issuer's 2022 annual stockholders meeting or June 3, 2022, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 17:38 UTC |
Hallam TrevorPres. Rsrch & Cf. Sctific Ofcr
|
GrantRestricted Stock Unit (RSU) · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-027600 · doc4.xml · derivative · entry 2 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2025-04-16 F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on April 16, 2022, subject to continued service through each vesting date. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 17:38 UTC |
Hallam TrevorPres. Rsrch & Cf. Sctific Ofcr
|
GrantStock Option (right to buy Common Stock) · Derivative | 20,000 | $0.00 Strike: $20.01 | $0.00 |
DisclosureSEC source: 0001209191-21-027600 · doc4.xml · derivative · entry 1 Hallam Trevor · CIK 0001326592 · Pres. Rsrch & Cf. Sctific Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-04-15 F1 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on May 16, 2021, with 100% of the total shares vested and exercisable on April 16, 2025, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 17:17 UTC |
Shabbir AnikChief Technical Ops. Officer
|
GrantRestricted Stock Unit (RSU) · Derivative | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018618 · doc4.xml · derivative · entry 2 Shabbir Anik · CIK 0001751728 · Chief Technical Ops. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2025-03-05 F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 17:17 UTC |
Shabbir AnikChief Technical Ops. Officer
|
GrantStock Option (right to buy Common Stock) · Derivative | 50,000 | $0.00 Strike: $21.11 | $0.00 |
DisclosureSEC source: 0001209191-21-018618 · doc4.xml · derivative · entry 1 Shabbir Anik · CIK 0001751728 · Chief Technical Ops. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-03-04 F1 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on April 5, 2021, with 100% of the total shares vested and exercisable on March 5, 2025, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 17:16 UTC |
ALBINI EDWARD CCFO and Secretary
|
GrantRestricted Stock Unit (RSU) · Derivative | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018617 · doc4.xml · derivative · entry 2 ALBINI EDWARD C · CIK 0001240014 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2025-03-05 F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 17:16 UTC |
ALBINI EDWARD CCFO and Secretary
|
GrantStock Option (right to buy Common Stock) · Derivative | 50,000 | $0.00 Strike: $21.11 | $0.00 |
DisclosureSEC source: 0001209191-21-018617 · doc4.xml · derivative · entry 1 ALBINI EDWARD C · CIK 0001240014 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-03-04 F1 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on April 5, 2021, with 100% of the total shares vested and exercisable on March 5, 2025, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 17:18 UTC |
FITZPATRICK LINDA AChief People & Comm. Officer
|
GrantRestricted Stock Unit (RSU) · Derivative | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018619 · doc4.xml · derivative · entry 2 FITZPATRICK LINDA A · CIK 0001188953 · Chief People & Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2025-03-05 F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 17:18 UTC |
FITZPATRICK LINDA AChief People & Comm. Officer
|
GrantStock Option (right to buy Common Stock) · Derivative | 50,000 | $0.00 Strike: $21.11 | $0.00 |
DisclosureSEC source: 0001209191-21-018619 · doc4.xml · derivative · entry 1 FITZPATRICK LINDA A · CIK 0001188953 · Chief People & Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-03-04 F1 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on April 5, 2021, with 100% of the total shares vested and exercisable on March 5, 2025, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 17:20 UTC |
NEWELL WILLIAM JDirector · CEO
|
GrantRestricted Stock Unit (RSU) · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018623 · doc4.xml · derivative · entry 2 NEWELL WILLIAM J · CIK 0001309660 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2025-03-05 F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 17:20 UTC |
NEWELL WILLIAM JDirector · CEO
|
GrantStock Option (right to buy Common Stock) · Derivative | 200,000 | $0.00 Strike: $21.11 | $0.00 |
DisclosureSEC source: 0001209191-21-018623 · doc4.xml · derivative · entry 1 NEWELL WILLIAM J · CIK 0001309660 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2031-03-04 F1 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on April 5, 2021, with 100% of the total shares vested and exercisable on March 5, 2025, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 17:19 UTC |
Hallam TrevorChief Scientific Officer
|
GrantRestricted Stock Unit (RSU) · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018620 · doc4.xml · derivative · entry 2 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2025-03-05 F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 17:19 UTC |
Hallam TrevorChief Scientific Officer
|
GrantStock Option (right to buy Common Stock) · Derivative | 60,000 | $0.00 Strike: $21.11 | $0.00 |
DisclosureSEC source: 0001209191-21-018620 · doc4.xml · derivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2031-03-04 F1 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on April 5, 2021, with 100% of the total shares vested and exercisable on March 5, 2025, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 22:20 UTC |
MOLINA ARTURO MDChief Medical Officer
|
GrantRestricted Stock Unit (RSU) · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018622 · doc4.xml · derivative · entry 2 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2025-03-05 F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 22:20 UTC |
MOLINA ARTURO MDChief Medical Officer
|
GrantStock Option (right to buy Common Stock) · Derivative | 60,000 | $0.00 Strike: $21.11 | $0.00 |
DisclosureSEC source: 0001209191-21-018622 · doc4.xml · derivative · entry 1 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2031-03-04 F1 · derivative.exercise_date: The option vests as to 2.0833% of the total shares monthly, beginning on April 5, 2021, with 100% of the total shares vested and exercisable on March 5, 2025, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 17:53 UTC |
Shabbir AnikChief Technical Ops. Officer
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006554 · doc4.xml · derivative · entry 3 Shabbir Anik · CIK 0001751728 · Chief Technical Ops. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 4,500 shares Expires 2024-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 17:53 UTC |
Shabbir AnikChief Technical Ops. Officer
|
Tax withholdingCommon Stock | 1,845 | $22.15 | $40,866.75 |
DisclosureSEC source: 0001209191-21-006554 · doc4.xml · nonDerivative · entry 2 Shabbir Anik · CIK 0001751728 · Chief Technical Ops. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,920 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 17:53 UTC |
Shabbir AnikChief Technical Ops. Officer
|
Exercise / conversionCommon Stock | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006554 · doc4.xml · nonDerivative · entry 1 Shabbir Anik · CIK 0001751728 · Chief Technical Ops. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 17:48 UTC |
ALBINI EDWARD CCFO and Secretary
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 5,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006550 · doc4.xml · derivative · entry 3 ALBINI EDWARD C · CIK 0001240014 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,750 Underlying: Common Stock · 5,250 shares Expires 2024-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 17:48 UTC |
ALBINI EDWARD CCFO and Secretary
|
Tax withholdingCommon Stock | 2,126 | $22.15 | $47,090.90 |
DisclosureSEC source: 0001209191-21-006550 · doc4.xml · nonDerivative · entry 2 ALBINI EDWARD C · CIK 0001240014 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,200 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 17:48 UTC |
ALBINI EDWARD CCFO and Secretary
|
Exercise / conversionCommon Stock | 5,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006550 · doc4.xml · nonDerivative · entry 1 ALBINI EDWARD C · CIK 0001240014 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 17:54 UTC |
FITZPATRICK LINDA AChief People & Comm. Officer
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 8,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006556 · doc4.xml · derivative · entry 4 FITZPATRICK LINDA A · CIK 0001188953 · Chief People & Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,750 Underlying: Common Stock · 8,250 shares Expires 2024-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F4 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 17:54 UTC |
FITZPATRICK LINDA AChief People & Comm. Officer
|
Tax withholdingCommon Stock | 3,147 | $22.15 | $69,706.05 |
DisclosureSEC source: 0001209191-21-006556 · doc4.xml · nonDerivative · entry 2 FITZPATRICK LINDA A · CIK 0001188953 · Chief People & Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,719 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 17:54 UTC |
FITZPATRICK LINDA AChief People & Comm. Officer
|
Exercise / conversionCommon Stock | 8,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006556 · doc4.xml · nonDerivative · entry 1 FITZPATRICK LINDA A · CIK 0001188953 · Chief People & Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 17:56 UTC |
NEWELL WILLIAM JDirector · CEO
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 13,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006559 · doc4.xml · derivative · entry 5 NEWELL WILLIAM J · CIK 0001309660 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,250 Underlying: Common Stock · 13,750 shares Expires 2024-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F5 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 17:56 UTC |
NEWELL WILLIAM JDirector · CEO
|
Tax withholdingCommon Stock | 7,061 | $22.15 | $156,401.15 |
DisclosureSEC source: 0001209191-21-006559 · doc4.xml · nonDerivative · entry 2 NEWELL WILLIAM J · CIK 0001309660 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,349 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 17:56 UTC |
NEWELL WILLIAM JDirector · CEO
|
Exercise / conversionCommon Stock | 13,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006559 · doc4.xml · nonDerivative · entry 1 NEWELL WILLIAM J · CIK 0001309660 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,410 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 17:55 UTC |
Hallam TrevorChief Scientific Officer
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 5,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006557 · doc4.xml · derivative · entry 3 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,750 Underlying: Common Stock · 5,250 shares Expires 2024-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 17:55 UTC |
Hallam TrevorChief Scientific Officer
|
Tax withholdingCommon Stock | 2,080 | $22.15 | $46,072.00 |
DisclosureSEC source: 0001209191-21-006557 · doc4.xml · nonDerivative · entry 2 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,287 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 17:55 UTC |
Hallam TrevorChief Scientific Officer
|
Exercise / conversionCommon Stock | 5,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006557 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 22:55 UTC |
MOLINA ARTURO MDChief Medical Officer
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 5,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006558 · doc4.xml · derivative · entry 3 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,750 Underlying: Common Stock · 5,250 shares Expires 2024-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 22:55 UTC |
MOLINA ARTURO MDChief Medical Officer
|
Tax withholdingCommon Stock | 2,107 | $22.15 | $46,670.05 |
DisclosureSEC source: 0001209191-21-006558 · doc4.xml · nonDerivative · entry 2 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,859 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 22:55 UTC |
MOLINA ARTURO MDChief Medical Officer
|
Exercise / conversionCommon Stock | 5,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006558 · doc4.xml · nonDerivative · entry 1 MOLINA ARTURO MD · CIK 0001398940 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,966 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2021 Filed Feb 1, 2022 20:32 UTC |
Shabbir AnikChief Technical Ops. Officer
|
Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006121 · doc4.xml · derivative · entry 3 Shabbir Anik · CIK 0001751728 · Chief Technical Ops. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 4,500 shares Expires 2025-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 17:05 UTC |
Petree Daniel HDirector
|
Exercise / conversionStock Option (right to buy Common Stock) · Derivative | 4,132 | $0.00 Strike: $4.36 | $0.00 |
DisclosureSEC source: 0001209191-21-005713 · doc4.xml · derivative · entry 3 Petree Daniel H · CIK 0001294939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,132 shares Expires 2021-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 17:05 UTC |
Petree Daniel HDirector
|
Exercise / conversionCommon Stock | 4,132 | $4.36 | $18,015.52 |
DisclosureSEC source: 0001209191-21-005713 · doc4.xml · nonDerivative · entry 1 Petree Daniel H · CIK 0001294939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,988 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 17:04 UTC |
Hallam TrevorChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,393 | $0.00 Strike: $4.36 | $0.00 |
DisclosureSEC source: 0001209191-21-005712 · doc4.xml · derivative · entry 4 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4 Underlying: Common Stock · 2,393 shares Expires 2021-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 17:04 UTC |
Hallam TrevorChief Scientific Officer
|
SaleCommon Stock | 165 | $26.10 | $4,306.15 |
DisclosureSEC source: 0001209191-21-005712 · doc4.xml · nonDerivative · entry 3 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,117 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.05 to $26.10 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 17:04 UTC |
Hallam TrevorChief Scientific Officer
|
SaleCommon Stock | 2,228 | $25.68 | $57,221.72 |
DisclosureSEC source: 0001209191-21-005712 · doc4.xml · nonDerivative · entry 2 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,282 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.05 to $25.91 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 17:04 UTC |
Hallam TrevorChief Scientific Officer
|
Exercise / conversionCommon Stock | 2,393 | $4.36 | $10,433.48 |
DisclosureSEC source: 0001209191-21-005712 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:21 UTC |
FITZPATRICK LINDA AChief People & Comm. Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,652 | $0.00 Strike: $4.36 | $0.00 |
DisclosureSEC source: 0001209191-21-004387 · doc4.xml · derivative · entry 3 FITZPATRICK LINDA A · CIK 0001188953 · Chief People & Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,652 shares Expires 2021-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:21 UTC |
FITZPATRICK LINDA AChief People & Comm. Officer
|
Exercise / conversionCommon Stock | 1,652 | $4.36 | $7,202.72 |
DisclosureSEC source: 0001209191-21-004387 · doc4.xml · nonDerivative · entry 1 FITZPATRICK LINDA A · CIK 0001188953 · Chief People & Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,616 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 14, 2021 Filed Jan 15, 2021 18:10 UTC |
Hallam TrevorChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 19,405 | $0.00 Strike: $4.36 | $0.00 |
DisclosureSEC source: 0001209191-21-003875 · doc4.xml · derivative · entry 2 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,405 shares Expires 2022-09-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 14, 2021 Filed Jan 15, 2021 18:10 UTC |
Hallam TrevorChief Scientific Officer
|
Exercise / conversionCommon Stock | 19,405 | $4.36 | $84,605.80 |
DisclosureSEC source: 0001209191-21-003875 · doc4.xml · nonDerivative · entry 1 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 17:00 UTC |
Hallam TrevorChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,393 | $0.00 Strike: $4.36 | $0.00 |
DisclosureSEC source: 0001209191-20-065371 · doc4.xml · derivative · entry 3 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,397 Underlying: Common Stock · 2,393 shares Expires 2021-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 17:00 UTC |
Hallam TrevorChief Scientific Officer
|
SaleCommon Stock | 2,393 | $22.37 | $53,530.21 |
DisclosureSEC source: 0001209191-20-065371 · doc4.xml · nonDerivative · entry 2 Hallam Trevor · CIK 0001326592 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,712 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.89 to $22.635 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.